Imunon, Inc. Other Long-term Investments
Imunon, Inc. (IMNN) had Other Long-term Investments of $3.75 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherLongTermInvestments · last filed 2024-03-28
- 2023-03-31: Other Long-term Investments $3.75M.
- 2022-12-31: Other Long-term Investments $4.50M.
- 2022-09-30: Other Long-term Investments $6.00M.
- 2022-06-30: Other Long-term Investments $6.00M.
| Period end | Other Long-term Investments |
|---|---|
| 2023-03-31 | $3.75M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.50M 10-K · filed 2024-03-28 |
| 2022-09-30 | $6.00M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $6.00M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $6.00M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $6.00M 10-K · filed 2023-03-30 |
| 2021-09-30 | $6.00M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $6.00M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |